Clinical Trials Logo

Spasticity clinical trials

View clinical trials related to Spasticity.

Filter by:

NCT ID: NCT03240601 Completed - Clinical trials for Spinal Cord Injuries

Spinal Cord Stimulation to Augment Activity Based Therapy

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

Involuntary muscle activity, often called spasticity, is a common problem following spinal cord injury (SCI) that can make it hard to move. Many things can cause spasticity including: muscle stretch, movement, or it can happen for no reason, and it is often described as an uncontrolled muscle spasm or feeling of stiffness. Drugs are typically used to treat spasticity, but they often have side effects, like muscle weakness, which can add to movement problems. Rehabilitation therapies offer alternatives to drugs for treating involuntary muscle activity, and rehabilitation can also improve daily function and quality of life. These benefits may be greater when several rehabilitation therapies are used together. Walking ability can be improved with a type of therapy called "locomotor training". This type of therapy may also have the benefit of decreasing spasticity. When locomotor training (LT) is combined with electrical stimulation, the benefits of training may be increased. In this study, investigators will use a kind of stimulation called transcutaneous spinal cord stimulation ("TSS") to stimulate participants' spinal cord nerves during locomotor training.

NCT ID: NCT03129529 Completed - Spasticity Clinical Trials

Comparing the Effect of Focused and Radial Extracorporeal Shock Waves on Post-stroke Hypertonia

Start date: January 1, 2016
Phase: N/A
Study type: Interventional

The main purpose of this study is to compare treatment efficacy of focused and radial extracorporeal shock waves on spasticity in chronic stroke patient

NCT ID: NCT02877836 Terminated - Spasticity Clinical Trials

Functional MRI and DTI in the Preoperative Assessment of Dystonia

IRMF-DIFF
Start date: September 19, 2014
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the organization of the motor circuit in a group of patients suffering from dystonia compared with a group of healthy controls. Deep Brain stimulation is a functional neurosurgery technique consisting in neuromodulation of the motor circuit that has been applied to dystonia. The efficiency of this technique depends on the relative preservation of the function and the structure of the motor network . The assessment of neuronal circuit by advanced techniques of functional neuroimaging in this study might contribute to expand our understanding of the abnormalities in motor circuit activation and the integrity of CNS structure underlying dystonia. This study might contribute therefore to the refinement of Deep brain stimulation indications and techniques in complex dystonia syndromes

NCT ID: NCT02718989 Not yet recruiting - Spasticity Clinical Trials

Modulation of H-reflex After Application of Electric Currents in Healthy People

Start date: June 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determinate whether the application of electric currents produce changes in the excitability of alpha moto neurone. Moreover evidence whether the effect of the electric currents can change the tone of the muscle under stimulation in healthy volunteers

NCT ID: NCT02718690 Completed - Spasticity Clinical Trials

Importance of the Current Density in TENS

Start date: December 2014
Phase: N/A
Study type: Interventional

The purpose of this study is demonstrate the importance of density current of TENS in the effect about H-reflex in healthy volunteers.

NCT ID: NCT02566837 Completed - Spasticity Clinical Trials

Use of Ultrasound in Injections of Botulinum Toxin

TOXINECHO
Start date: February 2012
Phase: N/A
Study type: Interventional

Intramuscular injections of botulinum toxin are currently the best focal treatment of spasticity, with clearly defined indications and role. French and European recommendations focus on the toxin's mode of administration, which must be as precise as possible. The toxin's specific action on motor endplates (blocking the release of acetylcholine) shows the importance of targeted injections within the muscle belly. The pain caused by these injections is due partly the number of injections (up to 30 in a single session), and partly to the use of electrical stimulation guidance. Prevention and alleviation of the pain caused by these injections have become a regulatory obligation since the law of 4 March 2002 relating to the rights of patients and the quality of the health system (" Any person has the right to receive relief from pain, which must, under all circumstances, be prevented, evaluated, taken into account and treated … ").

NCT ID: NCT02470325 Recruiting - Dystonia Clinical Trials

The Effects of Cannabis on Dystonia and Spasticity on Pediatric Patients

Start date: July 2015
Phase: Phase 2
Study type: Interventional

A clinical trial is planned to study the effects of cannabis on dystonia and spasticity in children with neurological diseases. The clinical trial will include 40 children divided into two groups: children with spasticity and dystonia due to cerebral palsy, and children with spasticity and dystonia due to genetic neurodegenerative diseases. Each group will be randomly divided into two arms and will receive Avidekel cannabis oil 6-to-1 ratio of CBD to THC or enriched Avidekel cannabis oil 20-to-1 ratio of CBD to THC. During the study, various variables will be collected including: medication intake, spasticity, dystonia score, pain scale, restlessness scale, quality of life measures, safety tests, side effects, and an addiction test. The investigators hypothesize that cannabis consumption will reduce dystonia and spasticity in children with motor disability related to genetic neurodegenerative diseases and cerebral palsy and as a result improve motor function, non-motor functions and quality of life.

NCT ID: NCT02400619 Completed - Cerebral Palsy Clinical Trials

Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT

Start date: September 2014
Phase: Phase 1
Study type: Interventional

Spasticity is a motor disorder that can affect the lower limbs in up to 75% patients with cerebral palsy, having a significantly effect on their mobility and quality of life. There is much controversy about what is the most appropriate treatment of spasticity The objective of the present study is to evaluate the effects of radial extracorporeal shock wave therapy (rESWT) compared to treatment with botulinum toxin to improve spasticity in patients with cerebral palsy The number needed of patients is 70 (35 per group). Leaving a period of washout between one therapy and the other

NCT ID: NCT02390206 Completed - Spasticity Clinical Trials

Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients

B-CAUSE
Start date: June 2015
Phase: N/A
Study type: Observational

The purpose of this study is to document the effectiveness of treating chronic post-stroke spastic patients with Botulinum Toxin type A.

NCT ID: NCT02334683 Completed - Spasticity Clinical Trials

Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia

Start date: October 28, 2015
Phase: N/A
Study type: Interventional

This study seeks to compare the use of ultrasound and electrophysiologic techniques to target muscles for the treatment of spasticity and focal dystonia of the limbs. The purpose of this study is to investigate the use of two ways of locating the muscle for botulinum toxin (BoNT) injection for the treatment of focal hand dystonia and upper limb spasticity. Electrophysiologic guidance, using electrical stimulation, and ultrasound are the standard ways of locating muscles during a treatment of BoNT injection.